Article Text

Download PDFPDF

Unlicensed and off label drug use in neonates
  1. Sharon Conroy,
  2. John McIntyre,
  3. Imti Choonara
  1. Academic Division of Child Health, University of Nottingham, Derbyshire Children’s Hospital, Derby DE22 3NE
  1. Mrs Sharon Conroy.

Abstract

AIM To determine the extent of use of drugs that are either not licensed (unlicensed), or are outside the terms of their product licence (off label) in a neonatal intensive care unit.

METHODS A prospective study was conducted over 13 weeks.

RESULTS 455 prescription episodes were administered to 70 babies. 63 (90%) patients were given a drug that was either unlicensed or used in an off label way. 54.7% prescription episodes were off label, many for more than one reason, and 9.9% (45) were unlicensed; 35.4% (161) prescription episodes were licensed.

CONCLUSION The use of unlicensed and off label drugs in neonatal intensive care seems to be far greater than other paediatric settings. This highlights the difficulties faced by those trying to ensure safe and effective prescribing for neonates. Urgent action is required to resolve this situation.

  • unlicensed/off label drug use
  • intensive care
View Full Text

Statistics from Altmetric.com

Footnotes

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.